Five-year Outcome of Bioresorbable Vascular Scaffold versus Drug-Eluting Stent for Coronary Artery Disease: A Meta-Analysis of Randomized Control Trial

被引：0
|
作者：
Putra, H. B. P. [1 ]
Mukhammad, W. W. [2 ]
Kembangsari, C. [2 ]
Jovie, B. [1 ]
Juslim, R. R. [1 ]
机构：
[1] Dr Ramelan Navy Hosp, Surabaya, Indonesia
[2] Hang Tuah Univ, Fac Med, Surabaya, Indonesia
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / 0F期
关键词：
Bioresorbable Vascular Scaffolds; Drug-Eluting Stent; Stent thrombosis;
D O I：
10.1093/eurheartjsupp/suab123.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M9
引用
收藏
页数：1
相关论文
共 50 条
  • [1] M9. Five-year Outcome of Bioresorbable Vascular Scaffold versus Drug-Eluting Stent for Coronary Artery Disease: A Meta-Analysis of Randomized Control Trial
    Putra, H. B. P.
    Mukhammad, W. W.
    Kembangsari, C.
    Jovie, B.
    Juslim, R. R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL F)
  • [2] Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis
    Nairooz, Ramez
    Saad, Marwan
    Sardar, Partha
    Aronow, Wilbert S.
    HEART, 2017, 103 (14) : 1096 - 1103
  • [3] Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease)
    De Palma, Rodney
    Byrne, Robert A.
    van Geuns, Robert-Jan
    Pilgrim, Thomas
    Jueni, Peter
    Al-Rashdan, Ibrahim
    EUROINTERVENTION, 2015, 11 (03) : 366 - 368
  • [4] Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
    Liu, Lulu
    Liu, Bin
    Ren, Jiajun
    Hui, Gang
    Qi, Chao
    Wang, Junnan
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [5] Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
    Lulu Liu
    Bin Liu
    Jiajun Ren
    Gang Hui
    Chao Qi
    Junnan Wang
    BMC Cardiovascular Disorders, 18
  • [6] A Systematic Review and Meta-Analysis of Bioresorbable Vascular Scaffold Versus Drug-Eluting Stents in Patients with Percutaneous Coronary Intervention
    Zhu Jianbing
    Ge, Junbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C47 - C47
  • [7] Five-Year Outcomes after Drug-Eluting Stent versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
    Park, Duk-Woo
    Lee, Jong-Young
    Kim, Won-Jang
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 16B - 16B
  • [8] Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
    Le Ni
    Hao Chen
    Zhurong Luo
    Yunqiang Yu
    Journal of Cardiothoracic Surgery, 15
  • [9] Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis
    Goel, Sunny
    Pasam, Ravi Teja
    Chava, Srilekha
    Sharma, Abhishek
    Malik, Bilal Ahmad
    Ayzenberg, Sergey
    Frankel, Robert
    Shani, Jacob
    Gidwani, Umesh
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (02) : 216 - 223
  • [10] Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
    Ni, Le
    Chen, Hao
    Luo, Zhurong
    Yu, Yunqiang
    JOURNAL OF CARDIOTHORACIC SURGERY, 2020, 15 (01)
12345